Peter M. Dansky
Directeur Général chez Agena Bioscience, Inc.
Profil
Peter M.
Dansky is currently the Chief Executive Officer & Director at Agena Bioscience, Inc. He previously held positions at Affymetrix, Inc. as Senior Director-Product Marketing & Informatics, PerSeptive Biosystems, Inc. as a Sales Representative, Biotheranostics, Inc. as Vice President-Marketing, Millipore Corp.
as an Engineering Supervisor, Applied Biosystems, Inc. as President-Molecular & Cell Biology, Life Technologies Corp.
as President-Molecular Biology Systems Division, and Arcturus Bioscience, Inc. as Vice President-Marketing.
Dansky holds an MBA from Boston College and undergraduate and graduate degrees from Tufts University.
Postes actifs de Peter M. Dansky
| Sociétés | Poste | Début |
|---|---|---|
Agena Bioscience, Inc.
 Agena Bioscience, Inc. Medical SpecialtiesHealth Technology Agena Bioscience, Inc. develops, manufactures and supplies genetic analysis systems and reagents. The firm’s system are mass spectrometry-based platform for genetic analysis, and is used globally in diverse research fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research. The company was founded in 2014 and is headquartered in San Diego, CA. | Directeur Général | 21/07/2014 |
Anciens postes connus de Peter M. Dansky
| Sociétés | Poste | Fin |
|---|---|---|
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Corporate Officer/Principal | 01/11/2008 |
| Millipore Corp. /Biosearch Division/ | Corporate Officer/Principal | - |
PerSeptive Biosystems, Inc.
 PerSeptive Biosystems, Inc. Medical SpecialtiesHealth Technology PerSeptive Biosystems developed and manufactured an integrated system for the purification, analysis, and synthesis of bio-molecules, reducing the time and cost of drug discoveries. BVP’s Chris Gabrieli invested in the company’s second round in December 1989. PerSeptive was purchased by Perkin Elmer, Inc. (NYSE: PKI) in 1998, it is a part of Applied Biosystems (NYSE: ABI), a subsidiary of Applera, Perkin Elmer’s former biotechnology division | Corporate Officer/Principal | - |
| AFFYMETRIX, INC. | Sales & Marketing | - |
Arcturus Bioscience, Inc.
 Arcturus Bioscience, Inc. Medical SpecialtiesHealth Technology Arcturus Bioscience, Inc. develops laser capture micro dissection instruments and reagents for the analysis of microscopic tissue samples. The private company is based in Carlsbad, CA. The company was founded by Antonius P. Schuh. | Sales & Marketing | - |
Formation de Peter M. Dansky
| Boston College | Masters Business Admin |
| Tufts University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
Arcturus Bioscience, Inc.
Arcturus Bioscience, Inc. Medical SpecialtiesHealth Technology Arcturus Bioscience, Inc. develops laser capture micro dissection instruments and reagents for the analysis of microscopic tissue samples. The private company is based in Carlsbad, CA. The company was founded by Antonius P. Schuh. | Health Technology |
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
PerSeptive Biosystems, Inc.
PerSeptive Biosystems, Inc. Medical SpecialtiesHealth Technology PerSeptive Biosystems developed and manufactured an integrated system for the purification, analysis, and synthesis of bio-molecules, reducing the time and cost of drug discoveries. BVP’s Chris Gabrieli invested in the company’s second round in December 1989. PerSeptive was purchased by Perkin Elmer, Inc. (NYSE: PKI) in 1998, it is a part of Applied Biosystems (NYSE: ABI), a subsidiary of Applera, Perkin Elmer’s former biotechnology division | Health Technology |
| Millipore Corp. /Biosearch Division/ | Health Technology |
Agena Bioscience, Inc.
Agena Bioscience, Inc. Medical SpecialtiesHealth Technology Agena Bioscience, Inc. develops, manufactures and supplies genetic analysis systems and reagents. The firm’s system are mass spectrometry-based platform for genetic analysis, and is used globally in diverse research fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research. The company was founded in 2014 and is headquartered in San Diego, CA. | Health Technology |
